Optimal Endpoints of Acute Heart Failure Therapy
نویسندگان
چکیده
منابع مشابه
Therapy for acute heart failure syndromes.
The pharmacologic management of acute heart failure syndromes (AHFS) has changed little over the past 15 years. Traditional therapies, such as nitrates and loop diuretics, remain the mainstay of therapy, with inotropes reserved for patients who present in shock or an advanced low-output state. We review the use of these therapies in AHFS with added insights from recent clinical trials and regis...
متن کاملDrug Therapy for Acute Heart Failure.
Acute heart failure is globally one of most frequent reasons for hospitalization and still represents a challenge for the choice of the best treatment to improve patient outcome. According to current international guidelines, as soon as patients with acute heart failure arrive at the emergency department, the common therapeutic approach aims to improve their signs and symptoms, correct volume o...
متن کاملThe Ongoing Evolution of Optimal Clinical Endpoints for Heart Failure Trials.
A dvances in heart failure (HF) drug and device therapies over the past 3 decades have made major inroads into the lethality of this disease. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), beta-blockers, mineralocorticoid receptor antagonists (MRAs), as well as device-based approaches including cardiac resynchronization therapy and implantable cardiover...
متن کاملOptimal decongestive therapy in acute decompensated heart failure syndromes: far from being solved.
We have read with great interest the article entitled “Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: The Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) Trial” [1]. First, we would like to commend the authors for their effort in carrying out this investigator-initiated clinical trial by testing the prognostic effect of three deconges...
متن کاملAcute heart failure facts and numbers: acute heart failure populations
Acute heart failure (AHF) is a life-threatening emergency, which largely profits from early diagnosis and treatment. The prevalence of AHF is difficult to assess, estimates range between 1 and 12% in the general population. Despite recent therapeutic advances, in-hospital mortality is high with estimates varying from 4 and 18% in different registries. Due to large differences in AHF definitions...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Therapeutics
سال: 2018
ISSN: 1075-2765
DOI: 10.1097/mjt.0000000000000792